Clinic
Pediatric Associates of West Memphis, PLLC
Pediatric Associates of West Memphis, PLLC was paid $10.60M by Medicaid between Jan 2018 and Dec 2024, across 55 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.
33Billing provider infoPEDIATRIC ASSOCIATES OF WEST MEMPHIS, PLLC
WEST MEMPHIS, AR 72301
WEST MEMPHIS, AR 72301
33aNPI1407966005assigned 08/30/2006
33bProvider typeClinic/Center
28Total paid$10.60M
24GClaims253,637
24DCodes billed55
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Arkansas
Rank by total paid#1 of 77
Median peer was paid$68K
This provider vs. median156×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 42,650 | $1.33M | |
| 2019 | 44,956 | $1.56M | |
| 2020 | 33,455 | $1.17M | |
| 2021 | 31,880 | $1.37M | |
| 2022 | 35,181 | $1.68M | |
| 2023 | 36,043 | $1.88M | |
| 2024incomplete | 29,472 | $1.60M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 46,205 | 42,254 | $3.18M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 54,167 | 50,805 | $1.90M |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 11% | 8,715 | 8,257 | $1.16M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.6% | 12,741 | 12,306 | $698K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.6% | 11,005 | 10,524 | $596K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.3% | 8,582 | 8,141 | $461K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.3% | 8,024 | 7,802 | $454K |
| 87631 | 3.8% | 4,751 | 4,487 | $404K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.1% | 7,068 | 6,720 | $332K |
| 87428 | 1.4% | 2,186 | 2,077 | $150K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 9,861 | 9,314 | $117K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.1% | 989 | 958 | $115K |
43 more codes
| 99203 | Doctor's office visit, new patient (routine) | 1.0% | 1,862 | $109K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,939 | $91K |
| 90670 | <1% | 7,342 | $79K | |
| 90647 | <1% | 5,944 | $70K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,573 | $68K |
| 90723 | <1% | 5,916 | $64K | |
| 83655 | <1% | 2,987 | $49K | |
| 99381 | <1% | 909 | $48K | |
| 87807 | <1% | 3,570 | $43K | |
| 90707 | <1% | 3,757 | $40K | |
| 90716 | <1% | 3,722 | $40K | |
| 90633 | <1% | 3,756 | $40K | |
| 90680 | <1% | 3,534 | $38K | |
| 81001 | <1% | 6,781 | $28K | |
| 90651 | <1% | 2,545 | $27K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 617 | $25K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 226 | $23K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 758 | $21K |
| 90734 | <1% | 1,857 | $20K | |
| 90619 | <1% | 655 | $14K | |
| 86308 | <1% | 2,045 | $14K | |
| 90686 | <1% | 965 | $14K | |
| 85018 | <1% | 4,112 | $13K | |
| 90715 | <1% | 830 | $9K | |
| 90696 | <1% | 745 | $8K | |
| 90688 | <1% | 846 | $8K | |
| 90677 | <1% | 506 | $6K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 134 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 395 | $5K |
| 90700 | <1% | 424 | $4K | |
| 96112 | <1% | 24 | $4K | |
| 69210 | <1% | 81 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 278 | $2K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 69 | $1K |
| 90674 | <1% | 68 | $934.49 | |
| 99383 | <1% | 14 | $733.33 | |
| 99384 | <1% | 14 | $671.11 | |
| T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | <1% | 365 | $532.80 |
| 96127 | <1% | 103 | $401.44 | |
| 90656 | <1% | 17 | $262.65 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 15 | $177.60 |
| 90658 | <1% | 17 | $162.52 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWEAVER, ROBIN (PRACTICE MANAGER)